SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 142 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,446,052 | -28.2% | 2,571,196 | -18.5% | 0.00% | -25.0% |
| Q2 2023 | $82,738,547 | +14.3% | 3,155,551 | +12.2% | 0.00% | 0.0% |
| Q1 2023 | $72,362,116 | -63.0% | 2,811,271 | -62.6% | 0.00% | -33.3% |
| Q4 2022 | $195,370,942 | +106.0% | 7,511,378 | +126.0% | 0.01% | 0.0% |
| Q3 2022 | $94,835,000 | -1.0% | 3,324,062 | -14.5% | 0.01% | 0.0% |
| Q2 2022 | $95,753,000 | +6.3% | 3,889,249 | +143.7% | 0.01% | +50.0% |
| Q1 2022 | $90,072,000 | +10.2% | 1,595,890 | +21.0% | 0.00% | 0.0% |
| Q4 2021 | $81,758,000 | -3.1% | 1,319,111 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $84,338,000 | -5.4% | 1,329,418 | +22.9% | 0.00% | -20.0% |
| Q2 2021 | $89,161,000 | +12.3% | 1,081,921 | +0.2% | 0.01% | 0.0% |
| Q1 2021 | $79,424,000 | +1.6% | 1,079,568 | +0.1% | 0.01% | 0.0% |
| Q4 2020 | $78,173,000 | +105.8% | 1,077,952 | +35.3% | 0.01% | +66.7% |
| Q3 2020 | $37,985,000 | +140.8% | 796,842 | +112.2% | 0.00% | +200.0% |
| Q2 2020 | $15,773,000 | +236.9% | 375,536 | +116.5% | 0.00% | – |
| Q1 2020 | $4,682,000 | -16.3% | 173,419 | +19.4% | 0.00% | – |
| Q4 2019 | $5,591,000 | – | 145,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |